Women and HIV: Emerging Issues in Clinical Management
|
|
- Winifred Gilbert
- 5 years ago
- Views:
Transcription
1 Women and HIV: Emerging Issues in Clinical Management Karen P. Beckerman, MD Assistant Professor Obstetrics, Gynecology and Reproductive Sciences University of California, San Francisco 30 November 2001
2 Epidemiology in the U.S. Heterosexual transmission of HIV-1 Manifestations of HIV in women Initiating therapy in women Reproductive Health and HIV Preconceptional and early pregnancy counseling Vertical Transmission Principles of care during pregnancy The global epidemic
3
4
5
6
7
8 U.S. Total Cases: as of June 1999 Total 711,344 Men 588,124 Women 114,621 Heterosexual 40 % Unknown 39% IV Drug Use 29% Transfusion <1% Children 8,590
9 Epidemiology In the United States, women represent the fastest growing group of new infections: % 19% 20% 23%
10 Heterosexual Transmission among U.S. Youth, 1999 Age Women Men % 7% % 7% Overall, 54% of youth did not report a risk factor.
11 Heterosexual Transmission in the rural U.S.! West: 52%! Southeast: 58% 33% of new infections occur among women 2/3 of men and women are infected sexually 69% of women had young children at home
12 Heterosexual Transmission, Observations:! These estimates are low.! IVDU is listed where any history exists.! Most unknowns are probably heterosexual.
13 A new female patient in your office is likely to be:! From any socioeconomic class.! The mother of small children (who must be tested). And unlikely to be:! A prostitute! An IV drug user
14 Manifestations of HIV disease among women! Male female transmission is 2-10x more efficient than female male! More virus is found in semen than in vaginal fluids! Vaginal surface area >> male urethra and foreskin
15 Manifestations of HIV disease among women! Women may be more likely than men to be diagnosed by screening alone.! Most common presenting complaint in women is candidal esophagitis.! Nevirapine rash is more common in women.! Women without transmission risk factors often go undiagnosed when presenting with recurrent pneumonia, candidiasis or cervical dysplasia.
16 Manifestations of HIV disease among women: Seborrheic dermatitis Women Men axilla face between breasts chin groin nasal area external ear auditory canal axilla
17 Manifestations of HIV disease among women! Viral load was 50% lower in women than men! More rapid declines in CD4 over time! Findings may be confounded by race Anastos et al., 2000, JAIDS.24:218
18 Manifestations of HIV disease among women Other than reproduction, there are not major gender differences in the natural history of HIV disease.
19 Initiating antiretroviral Therapy (NIH Guidelines 13 August 2001: hivatis.org)! When symptomatic: any CD4 and any viral load! Asymptomatic with AIDS, CD4<200 treat.! Asymptomatic with CD4 between 200 & 350 offer treatment.! Asymptomatic with CD4 > 350, VL>55,000 *3 year risk of AIDS >30% recommend treatment, or defer with frequent monitoring! Asymptomatic with CD4 > 350, VL <55,000 many experts would defer therapy
20 Initiating antiretroviral Therapy (NIH Guidelines 13 August 2001: hivatis.org) For women with CD4 > 350, clinicians may consider beginning therapy at lower VL than in men. However, we have insufficient data to recommend a VL cut-off for women.
21 Reproductive Health among HIV-infected Women! Baseline colposcopy at HIV diagnosis! Pelvic and cervical pap smear every six months, at least initially! The role of anal Pap smears remains to be defined! Treat genital warts! Test for other sexually transmitted diseases
22 Reproductive Health among HIV-infected Women: CERVICAL DYSPLASIA & HPV! Immunosuppression is associated with increased susceptibility to HPV! Cervical dysplasia is 2x as common among women with AIDS diagnosis! Standard cervical pap tests may miss vaginal, vulvar or anal dysplasia! Colposcopy for ASCIS, AGCUS, low grade and high grade SIL or persistant inflammation
23 Contraceptive and Safe Sex Counseling! Must be addressed!! Barrier method (male or female condom) is required for STD protection.! Impact of hormonal contraception on HIV shedding?! Bioavailability of ethinyl estradiol in contraceptives may be significantly reduced by ritonavir, nelfinavir or nevirapine.
24 Contraceptive and Safe Sex Counseling! HIV-infected women must have access to all approved forms of contraception!! Back-up methods (tubal ligation, hormonal contraception) to barrier methods are acceptable and recommended.
25 Preconceptional and Early Pregnancy Counseling! Availability of antibody testing! NON-DIRECTIVE and SUPPORTIVE for client s reproductive choice: -Pregnancy does not affect course of HIV in the industrialized world -It is quite possible to have a normal pregnancy and an uninfected baby -For all women, early abortion is generally safer than pregnancy
26 First things first: Safe shelter Food Self-determination
27 Preconceptional and Early Pregnancy Counseling! Confirm serostatus, especially in areas of low sero-prevalence where the positive predictive value of a single test may be low! Obstetrical and gynecological history! History of HIV care, antiretrovirals, resistance! Physical examination
28 Preconceptional and Early Pregnancy Counseling: LABORATORY STUDIES:! Rubella and varicella antibodies! Toxoplasma antibody! CMV serostatus! Hepatitis serology! Syphillis serology! Chlamydia, GC testing! Baseline chest radiograph
29 Preconceptional and Early Pregnancy Counseling: Optimization of care:! If already taking ART, optimize -Switch from efavirenz to nevirapine -Consider switch from amprenavir to Kaletra (ritonavir/lopinavir) -Adherence, current and future! Discuss and optimize OI prophylaxis! Address nutritional needs! Consider extra folate supplement! Optimize control of other medical conditions
30 Preconceptional and Early Pregnancy Counseling:! Therapeutic options during pregnancy No medications Prophylaxis alone Other effects of ART (anemia, resistance, etc.)! Options for labor and delivery! Prophylaxis for neonates! Diagnostic procedures for exposed infants
31 Pneumocystis Pneumonia during the first year of life carries a >90% fatality rate
32 Diagnostic procedures for exposed infants:! Aimed at diagnosis at earliest time to intervene prior to clinical immunodeficiency.! Viral test (DNA-PCR or RNA-PCR) at: birth three months one month six months! Antibody test at: 12 months, 18 months or until antibody clears! Viral test at three months is highly predictive of infection status *Seroreversion is gold standard*
33 Prophylaxis procedures for exposed infants:! Zidovudine syrup 2mg/kg q 6h for six weeks! Trimethoprim-sulfa OI prophylaxis from 6 weeks to 6 months! Recommendations do not exist for dealing with maternal zidovudine resistance! Rarely, an infant might be given more than one medication for prophylaxis! Some authorities are allowing mothers not to give TMP-sulfa when risk of transmission is low
34 Preconceptional and Early Pregnancy Counseling:! Review adherence issues during pregnancy and post-partum! Discuss guardianship and other legal issues! Domestic violence issues! Discuss fertility, conception and safe sex! Risks of vertical transmission and pediatric HIV disease! Discuss advanced maternal age! Neural tube defect screening
35 Preconceptional and Early Pregnancy Counseling:! Access to clinical trials and other research! Peer counseling and peer support
36 Preconceptional and Early Pregnancy Counseling Observations:! Isolation is a major problem for infected women everywhere.! Many have never met another HIV- infected woman.! Most have never even heard of an infected mother or pregnant woman.! One-half of US HIV-infected women report domestic violence.
37 Preconceptional and Early Pregnancy Counseling Risk of vertical transmission:! Among women taking potent antiretroviral cocktails risk is not published - may be close to 1%.! Exposed infants will need six or more blood tests before two years of age to rule out HIV infection.
38 Vertical Transmission Mechanisms:! Unknown!! Exposure to maternal secretions?! Exposure to maternal blood at delivery? Via the placenta?
39 Vertical Transmission Maternal risk factors:! Maternal immune status: maternal CD4! Disease activity: maternal viral load (Garcia et al., NEJM 341:394)! Antiretroviral prophylaxis! Antiretroviral therapy! Prior infected child! Weight loss, Tb, OIs
40 Length of ruptured membranes(hours)
41 Vertical Transmission Obstetrical risk factors:! Length of ruptured membranes! Prematurity, low birth weight! Immune activation during pregnancy or at delivery?! Evidence of chorioamnionitis: infection or inflammation of membranes/placenta
42 Principles of care of the HIV-1 infected pregnant mother First things first:! Safe housing! Adequate nutrition! Transportation! Self-determination for: reproductive choice treatment & prophylaxis
43 Priniciples of care of the HIV-1 infected pregnant mother When mother is already on stable HAART with good control:! Encourage continuation of regimen through 1st trimester. >20,000 reports to the Antiretroviral Pregnancy Registry - no increase in congenital malformations.! Offer option of brief treatment interruption. Advise patient that VL will certainly rebound, but that stopping all ART at once may be safe for a few months
44 Priniciples of care of the HIV-1 infected pregnant mother When mother is not on stable HAART, or is experiencing virologic breakthrough:! Do not start therapy or change therapy until the second trimester. >Nausea and vomiting during the first trimester make it a very poor time to start new therapies.! Offer: >Continuation of therapy with a change in 2nd trimester. >Brief treatment interruption. >Start of therapy in 2nd trimester.
45 Priniciples of care of the HIV-1 infected pregnant mother Antiretrovirals that should be avoided if possible: EFAVIRENZ:! Unpublished primate data show high incidence of neural tube defects.! No reports in humans.! No indication, per se, to abort pregnancy.! Multiple ultrasound and blood tests can rule out neural tube defects.! Consider a switch to nevirapine.
46 Priniciples of care of the HIV-1 infected pregnant mother Antiretrovirals that should be avoided if possible: AMPRENAVIR:! Unpublished reports of abnormal calcification of bones.! Human data are lacking.! Consider a switch to another highly potent agent or combination, such as lopinavir/ritonavir.
47 Priniciples of care of the HIV-1 infected pregnant mother Antiretrovirals that should be avoided if possible: STAVUDINE/DIDANOSINE (D4T/ddI):! High potency nrti combination.! Particularly effective in the setting of pan-resistance and virologic breakthrough.! Given alone short term in South Africa, was highly effective at preventing MCT, without lactic acidosis.! Reports of lactic acidosis during pregnancy.! If needed, requires very frequent monitoring of liver transaminases.
48 Prophylaxis for Opportunistic Infection Trimethoprim-sulfa Dapsone Azithromycin >may all be used safely during pregnancy >pregnancy is not a good time to stop OI prophylaxis
49 Principles of care of the HIV-1 infected pregnant mother Protection of mothers from mono- and dual therapies likely to induce ART resistance:
50 Low Fidelity HIV-1 Replication
51 Low Fidelity HIV-1 Replication Two polymerases without proofreading activity HIV-1 reverse transcriptase Cellular RNA polymerase Two RNA copies per virion Insertions and deletions are common RNA strand breaks force template switching Uracil incorporation into proviral DNA Especially in resting cells
52 Pregnancy and ART resistance in Uganda NVP single dose prophylaxis: HIVNET 006 & 012 Single dose to mother + single dose to infant Transmission fell from 25 to 13% "10 of 46 mothers studied 6 weeks to 6 months later had detectable resistance "Of the 36 infected infants, 8 had detectable nnrti resistance at 6 weeks of age.
53 Pregnancy and ART resistance in the developed world
54 Principles of care of the HIV-1 infected pregnant mother Protection of mothers from mono- and dualtherapies likely to induce resistance: Nevirapine prophylaxis (even one dose) is highly likely to result in nnrti resistance if not given in a safe combination. In the U.S., nevirapine prophylaxis given in addition to standard ART resulted in no benefit to mother or baby, but did cause significant induction of nnrti resistance. (Dorenbaum, PACTG 316, CROI, 2001)
55 Pregnancy and ART resistance in the developed world Zidovudine/lamivudine (AZT/3TC) induces resistance (M184V) at same frequencies in pregnant women as in men In one study, 4 of 5 mothers developed M184V (Clark, J Med Virol.59:364) M184V can be transmitted to neonates
56 Pregnancy and ART resistance in the U.S. and Japan Are these data relevant to us today? Unfortunately, YES. ACTG 185: late 1990s "86% received ZDV 14% received ZDV/3TC "30% of mothers had nrti resistance by delivery "These mothers were 3 times more likely to transmit virus to their infant (p=0.03)
57 Principles of care of the HIV-1 infected pregnant mother Protection of mothers from mono- and dualtherapies likely to induce resistance: Women refusing 3 medications should be offered zidovudine prophylaxis, never Combivir alone. Combivir Alone
58 Priniciples of care of the HIV-1 infected pregnant mother Aggressive use of combination antiretroviral therapy to achieve durable suppression of maternal HIV replication and to protect mother from induction of antiretroviral resistance:! Offer 3 or more medications! Twice daily dosing
59 Principles of care of the HIV-1 infected pregnant mother Cytochrome p4503a reductase activity:! AUC 8 for indinavir is markedly suppressed late in pregnancy! p450 3A activity is significantly increased in the third trimester (Homma et al., 2001; Hayashi et al. 2001)! Increased p450 3A activity in late pregnancy is reversed by ritonavir, allowing twice daily dosing, for example, RTV200mg/IDV800mg q 12 h
60 Principles of care of the HIV-1 infected pregnant mother Aggressive use of combination antiretroviral therapy to achieve durable suppression of maternal HIV replication and to protect mother from induction of antiretroviral resistance:! When likelihood of nonadherence is high, do not offer nevirapine! If mother does not need therapy for her own health, HAART can be safely stopped post-partum
61 Route of delivery Informed maternal choice: Retrospective evidence of prevention of vertical transmission by elective cesarean delivery Hours of membrane rupture
62
63
64 Route of delivery Informed maternal choice: No data exist that demonstrate a benefit of elective cesarean to mother or baby when mother is receiving potent combination therapy.
65 University of California/San Francisco General Hospital
66 University of California/San Francisco General Hospital
67 San Francisco,
68 Length of rupture of membranes, (hours) Shaffer et al., Viral Load and Transmission
69 Control of maternal viral load appears to be highly protective even in the setting of prolonged rupture of membranes
70
71
72
73 November 2001: > 40 million infected >8,000 deaths per day 600 new infections per hour a child dies every minute
74
75
76 By 2010, >42 million orphans. They will suffer greatly, whether they are infected...
77 or not.
78
79
80
81
82
83
84 Japanese AIDS Research Society Dr. Aikichi Iwamoto Dr. Atsushi Ajisawa Dr. Makoto Aoki Ms.Narumi Hori GlaxoSmithKline Medicus Tokyo
CUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA. Date
CUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA 350 300 250 Number 200 150 100 50 0 1/01/1997 1/01/1998 1/01/1999 1/01/2000 31/12/2000 31/12/2001 31/12/2002 Date July 2004 Reported number of perinatally exposed
More information2016 Perinatal Treatment Guidelines Update
Mountain West AIDS Education and Training Center 2016 Perinatal Treatment Guidelines Update Shireesha Dhanireddy, MD Associate Professor of Medicine, University of Washington 2 November 2016 This presentation
More informationObstetric Complications in HIV-Infected Women. Jeanne S. Sheffield, MD Maternal-Fetal Medicine UT Southwestern Medical School
Obstetric Complications in HIV-Infected Women Jeanne S. Sheffield, MD Maternal-Fetal Medicine UT Southwestern Medical School Obstetric Complications and HIV Obstetric complications are not increased in
More informationPAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist
PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical
More informationWhat s New. In The 2016 Perinatal HIV Treatment Guidelines? Provided by CDC s Elimination of Perinatal HIV Transmission Stakeholders Group
What s New In The 2016 Perinatal HIV Treatment Guidelines? Provided by CDC s Elimination of Perinatal HIV Transmission Stakeholders Group Guidelines for our Online Meeting Room You will be listening to
More informationHIV Infection in Pregnancy. Francis J. Ndowa WHO RHR/STI
HIV Infection in Pregnancy Francis J. Ndowa WHO RHR/STI FJN_STI_2005 Department of reproductive health and research Département santé et recherche génésiques Session outline Effect of pregnancy on HIV
More informationtreatment during pregnancy and breastfeeding
treatment during pregnancy and breastfeeding Topics covered Introduction. Preventing parent-to-child transmission. AZT as a single therapy. Treatment begun late in pregnancy. Nevirapine for mothers and
More informationSUMMARY TABLE OF SEXUALLY TRANSMITTED INFECTIONS
1 of 5 SUMMARY TABLE OF SEXUALLY TRANSMITTED INFECTIONS Sexually Transmitted Infections How is it spread? How do I get tested? Can it be cured? fertility? pregnancy? a newborn? Can the mother breastfeed
More informationAntiretroviral Therapy During Pregnancy and Delivery: 2015 Update
Frontier AIDS Education and Training Center Antiretroviral Therapy During Pregnancy and Delivery: 2015 Update Brian R. Wood, MD Assistant Professor of Medicine, University of Washington Medical Director,
More informationLabor & Delivery Management for Women Living with HIV. Pooja Mittal, DO Lisa Rahangdale, MD
Labor & Delivery Management for Women Living with HIV Pooja Mittal, DO Lisa Rahangdale, MD Statistics for Perinatally Acquired HIV Timing of Perinatal HIV Transmission Most transmission occurs close to
More informationObstetrics and HIV An Update. Jennifer Van Horn MD University of Utah
Obstetrics and HIV An Update Jennifer Van Horn MD University of Utah Obstetrics and HIV Perinatal transmission Testing Antiretroviral therapy Antepartum management Intrapartum management Postpartum management
More informationTunisian recommendations on ART : process and results
Second Arab Congress of Clinical Microbiology and Infectious Diseases May 24-26, 2012. Tunisian recommendations on ART : process and results M. BEN MAMOU UNAIDS Email: BenmamouM@unaids.org M. CHAKROUN
More informationUNIT TWO: OBSTETRICS EDUCATIONAL TOPIC 17: MEDICAL AND SURGICAL COMPLICATIONS OF PREGNANCY
UNIT TWO: OBSTETRICS EDUCATIONAL TOPIC 17: MEDICAL AND SURGICAL COMPLICATIONS OF PREGNANCY Rationale: Medical and surgical conditions may alter the course of pregnancy. Likewise, pregnancy may have an
More informationThe Impact of Sexually Transmitted Diseases(STD) on Women
The Impact of Sexually Transmitted Diseases(STD) on Women GAL Community Symposium AUM September 2, 2011 Agnes Oberkor, MPH, MSN, CRNP, Nurse Practitioner Senior Alabama Department of Public Health STD
More informationPreventing Mother to Child HIV Transmission: Are We There Yet?!'
Preventing Mother to Child HIV Transmission: Are We There Yet?!' 2017 Michigan Clincal Nursing Conference for HIV and STD Care May 18, 2017 Frankenmuth MI 1 Theodore B. Jones, MD Maternal Fetal Medicine
More information0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920
0.14 UNAIDS 0.053% 2 250 60 10% 94 73 20 73-94/6 8,920 12 43 Public Health Service Task Force Recommendations 5-10% for Use of Antiretroviral Drugs in 10-20% Pregnant HIV-1-Infected Women for Maternal
More informationPerinatal HIV Exposure: Antiretroviral Management. Danielle McDonald, PharmD PGY-2 Pediatric Pharmacotherapy Resident
Perinatal HIV Exposure: Antiretroviral Management Danielle McDonald, PharmD PGY-2 Pediatric Pharmacotherapy Resident A presentation for HealthTrust Members June 1, 2018 Learning Objectives for Pharmacists
More informationTreatment experience in South Africa. Dr Ian Sanne Clinical HIV Research Unit University of the Witwatersrand
Treatment experience in South Africa Dr Ian Sanne Clinical HIV Research Unit University of the Witwatersrand Overview South African Prevalence Adherence Combination ddi + d4t Nevirapine Hepatotoxicity
More informationWHAT S NEW IN THE 2015 PERINATAL HIV GUIDELINES?
WHAT S NEW IN THE 2015 PERINATAL HIV GUIDELINES? Today s Webinar will be starting soon For the audio portion of this meeting: Dial 1-855-702-5382 Enter participant code 596-825-4701# Guidelines for online
More informationPOST-EXPOSURE PROPHYLAXIS, PRE-EXPOSURE PROPHYLAXIS, & TREATMENT OF HIV
POST-EXPOSURE PROPHYLAXIS, PRE-EXPOSURE PROPHYLAXIS, & TREATMENT OF HIV DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none
More informationWomen are the fastest-growing group of persons with
Clinical Guidelines Prenatal Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force Roger Chou, MD; Ariel K. Smits, MD, MPH; Laurie Hoyt Huffman, MS; Rongwei Fu, PhD; and
More informationPRECONCEPTION COUNSELING
PRECONCEPTION COUNSELING A Counseling Guide for Healthcare Providers Preconception Care & Counseling 1 Introduction Pregnancy planning and preconception care are important in order to: 1. Ensure maternal
More informationTOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV
TOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV Gladwel Muthoni KPA Conference 24 th April, 2018 OUTLINE Burden of HIV in PMTCT Mechanism and timing of Mother to Child Transmission (MTCT) Four
More informationTHE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010
THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 The South African Antiretroviral Treatment Guidelines 2010 Goals of the programme Achieve best health outcomes in the most cost-efficient manner
More information17a. Sexually Transmitted Diseases and AIDS. BIOLOGY OF HUMANS Concepts, Applications, and Issues. Judith Goodenough Betty McGuire
BIOLOGY OF HUMANS Concepts, Applications, and Issues Fifth Edition Judith Goodenough Betty McGuire 17a Sexually Transmitted Diseases and AIDS Lecture Presentation Anne Gasc Hawaii Pacific University and
More informationWhat Women Need to Know: The HIV Treatment Guidelines for Pregnant Women
: The HIV Treatment Guidelines for Pregnant Women : The HIV Treatment Guidelines for Pregnant Women What Women Need to Know: Prepared by Elaine Gross, RN, MS, CNS-C National Pediatric & Family HIV Resource
More informationMichigan Guidelines: HIV, Syphilis, HBV in Pregnancy
Michigan Guidelines: HIV, Syphilis, HBV in Pregnancy Presenter: Theodore B. Jones, MD Maternal Fetal Medicine Wayne State University School of Medicine Beaumont Dearborn Hospital HIV, Syphilis, HBV in
More informationUse of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH
Use of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH University of Pittsburgh Medical Center Disclosures Presenter has no financial interests to
More informationContraception for Women and Couples with HIV. Knowledge Test
Contraception for Women and Couples with HIV Knowledge Test Instructions: For each question below, check/tick all responses that apply. 1. Which statements accurately describe the impact of HIV/AIDS in
More informationTB/HIV/STD Epidemiology and Surveillance Branch. First Annual Report, Dated 12/31/2009
TB/HIV/STD Epidemiology and Surveillance Branch First Annual Report, Dated 12/31/29 This Enhanced Perinatal Surveillance Report is the first annual report generated by the Texas Department of State Health
More informationImportant Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP)
Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) For Healthcare Providers About Emtricitabine/Tenofovir Disoproxil
More informationPrevention of Perinatal HIV Transmission
Prevention of Perinatal HIV Transmission Emily Adhikari, MD Division of Maternal-Fetal Medicine Obstetrics and Gynecology University of Texas Southwestern Medical Center February 20, 2018 None Understand
More informationAppendix 1: summary of the modified GRADE system (grades 1A 2D)
Appendix 1: summary of the modified GRADE system (grades 1A 2D) 1A 1B 1C 1D 2A 2B 2C 2D Strong recommendation High-quality evidence Benefits clearly outweigh risk and burdens, or vice versa Consistent
More informationHIV and Public Health: the Basics
HIV and Public Health: the Basics Joy Zeh, RN, MS, Family Nurse Practitioner VCU HIV/AIDS Center HIV and Public Health: the Basics Epidemiology Related Infections and Co-Morbidities Spectrum of HIV Infection
More informationPost-Sexual Exposure Prophylaxis (npep)
Projeto Praça Onze Universidade Federal do Rio de Janeiro Post-Sexual Exposure Prophylaxis (npep) Mauro Schechter Principal Investigator, Projeto Praça Onze Professor of Infectious Diseases Universidade
More informationBilling and Coding for HIV Services
Billing and Coding for HIV Services Financial Disclosure This speaker does not have any financial relationships with commercial entities to disclose. This speaker will not discuss any off-label use or
More informationPREVENT TRANSMISSION OF HIV/AIDS PREGNANT WOMEN : LITERATUR REVIEW
PREVENT TRANSMISSION OF HIV/AIDS PREGNANT WOMEN : LITERATUR REVIEW *Nunung Nurhayati STIKep PPNI Jawa Barat, Bandung, West Java Indonesia Email: nunky_adzra@yahoo.com ABSTRACT Baby risk be infected HIV/AIDS
More informationHIV/AIDS MEASURES GROUP OVERVIEW
2014 PQRS OPTIONS F MEASURES GROUPS: HIV/AIDS MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN HIV/AIDS MEASURES GROUP: #159. HIV/AIDS: CD4+ Cell Count or CD4+ Percentage Performed #160. HIV/AIDS: Pneumocystis
More informationversus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects
PRE-CONFERENCE WORKSHOPS WEDNESDAY, 24 OCTOBER 2018 10h00 14h00 Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop ITREMA trial feedback PrEP for the private
More informationComprehensive Guideline Summary
Comprehensive Guideline Summary Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents AETC NRC Slide Set Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and
More informationInfertility Treatment and HIV
Infertility Treatment and HIV Infertility Treatment by IVF Or Intra-cytoplasmic Sperm Injections (ICSC) In Chronic HIV-1 Sero- discordant Couples (Poster 670) Retrospective study of outcome of IVF or ICSC
More informationConcomitant antiretroviral therapy : Avifanz must be given in combination with other antiretroviral medications.
Avifanz Tablet Description Avifanz is the brand name for Efavirenz. Efavirenz, a synthetic antiretroviral agent, is a non-nucleoside reverse transcriptase inhibitor. While Efavirenz is pharmacologically
More informationPrinciples of Antiretroviral Therapy
Principles of Antiretroviral Therapy Ten Principles of Antiretroviral Therapy Skills Building Workshop: Clinical Management of HIV Infection and Antiretroviral Therapy, 11 th ICAAP, November 21st, 2011,
More informationRegister for notification of guideline updates at
Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States Visit the AIDSinfo website
More informationHIV IN PREGNANCY. Practices for Maintaining Maternal Health and Preventing Perinatal HIV Transmission. University of Tennessee Health Science Center
HIV IN PREGNANCY Practices for Maintaining Maternal Health and Preventing Perinatal HIV Transmission Nina K. Sublette, PhD, FNP University of Tennessee Health Science Center College of Nursing: Department
More informationNon-occupational HIV Post Exposure Prophylaxis (npep)
Mountain West AIDS Education and Training Center Non-occupational HIV Post Exposure Prophylaxis (npep) Robert Harrington, M.D. This presentation is intended for educational use only, and does not in any
More informationCCC ARV Dosing Recommendations for HIV-exposed infants Updated
USERS NOTE: Please note this document does not provide guidance on overall decisionmaking regarding what medication(s) to use for HIV-exposed infants. This document is meant to facilitate ARV dosing for
More informationfor Women Living with HIV Infection
Preconception Counseling for Women Living with HIV Infection Introduction Routine incorporation of preconception care and counseling in primary care settings is needed in order to: 1. Prevent unintended
More informationHIV/AIDS Prenatal Care for HIV+ Mothers. 1. Algorithm for Prenatal Screening & Care (Antepartum)
7/10/18 njm 1. Algorithm for Prenatal Screening & Care (Antepartum) 2. Algorithm for Prenatal HIV Screening and Care (Mother refuses screening) 3. Algorithm for Intrapartum Care 4. Prenatal Care for HIV+
More informationMalaysian Consensus Guidelines on Antiretroviral Therapy Cheng Joo Thye Hospital Raja Permaisuri Bainun Ipoh
Malaysian Consensus Guidelines on Antiretroviral Therapy 2017 Cheng Joo Thye Hospital Raja Permaisuri Bainun Ipoh Acknowledgement Table of contents Evolution of when to initiate therapy ART improves survival
More informationANTIRETROVIRAL (ART) DRUG INFORMATION FOR HEALTH CARE PROFESSIONAL
ZIDOVUDINE (AZT, Retrovir ) Benefits of zidovudine: Zidovudine (ZDV) is an antiretroviral drug that slows the growth of the HIV virus. It has shown in a large randomized, multicentre study to decrease
More informationManagement of the HIV-Exposed Infant
Management of the HIV-Exposed Infant Katherine Knapp, MD Medical Director, Perinatal Program Department of Infectious Diseases St. Jude Children s Research Hospital Disclosures No conflicts of interest
More informationContinuing Education for Pharmacy Technicians
Continuing Education for Pharmacy Technicians HIV/AIDS TREATMENT Michael Denaburg, Pharm.D. Birmingham, AL Objectives: 1. Identify drugs and drug classes currently used in the management of HIV infected
More informationGuidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft:
Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: 10-2-2015 Clinical studies demonstrate that when a person without HIV infection takes
More informationHIV infection in pregnancy
HIV infection in pregnancy Peter Brocklehurst National Perinatal Epidemiology Unit, University of Oxford What is the size of the problem? in the population as a whole? in women? in pregnant women? in children?
More information1. Which of the following is an addition to components of reproductive health under the new paradigm
Population Change and Public Health Exercise 11A 1. Which of the following is an addition to components of reproductive health under the new paradigm A. Safe motherhood B. Provision of family planning
More informationAction Item for 2019 Review of Tool. Maintain (add include oral cavity) Maintain. Archive. Archive. 12 creatinine)
NEWLY DIAGNOSED/ NEW TO CARE PROGRAM SITE: REVIEWER(S): REVIEW DATE: CORE SERVICES Outpatient/Ambulatory Health Services Tool - 2018 (OLD) SECTION 1: CHART REVIEW Review for newly diagnosed HIV patients
More informationCalifornia Perinatal Quality Care Collaborative 2013 Standards of Care for the Prevention of Perinatal HIV Transmission
2013 Revised Edition Authors: David K Hong, MD, Nivedita Srinivas, MD Original Authors: Mary Campbell Bliss, RN, MS, CNS, William Gilbert, MD, Jan Lanouette, MD, Courtney Nisbet, RN, MS, David Wirtschafter,
More informationHIV in Pregnancy. In Practice. Cheryl Roth Pauline F. Hrenchir Christine J. Pacheco
In Practice Photo istock Collection / thinkstockphotos.com IImagine this scenario: You are working on a Saturday afternoon when a woman comes into the obstetrics triage unit. She is pregnant for the fourth
More informationRecommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and
Recommendations for Use of Antiretroviral s in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States, June 23, 2004, CDC and updated
More informationThe Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings.
The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings Counseling Cards Checklist to be reasonably sure a woman is not pregnant
More informationChapter 20: Risks of Adolescent Sexual Activity
Unit 7 Lesson 7.1 Notes Introductory Video Video STIs: Running the Risk Chapter 20: Risks of Adolescent Sexual Activity Section 1: What Are the Risks? Key Terms: Sexually Transmitted Disease (STD) an infectious
More informationAll HIV-exposed Infants Should Receive Triple Drug Antiretroviral Prophylaxis. Against the motion
All HIV-exposed Infants Should Receive Triple Drug Antiretroviral Prophylaxis Against the motion Hermione Lyall Imperial Healthcare NHS Trust, London, UK Acknowledgements: Pat Tookey, Ali Judd, Claire
More informationHIV, Women, & Pregnancy
HIV, Women, & Pregnancy Facts, Myths, and Management Nina K. Sublette, PhD, ACRN, AACRN, FNP University of Tennessee Department of Obstetrics and Gynecology St. Jude Children s Research Hospital Department
More informationPerinatal Care and Prevention. Jennifer Janelle, MD Assistant Professor of Medicine University of Florida at Gainesville
Perinatal Care and Prevention Jennifer Janelle, MD Assistant Professor of Medicine University of Florida at Gainesville Objectives Develop patient centered, team based, treatment and delivery plans to
More informationPROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV
PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV Madhuri Lad, DO, FACOI, AAHIVS Clinical Assistant Professor OSU Department of Internal Medicine OBJECTIVES Demographics Definitions Diagnosis
More informationSexually Transmi/ed Diseases
Sexually Transmi/ed Diseases Chapter Fourteen 2013 McGraw-Hill Higher Education. All rights reserved. Also known as sexually transmitted infections The Major STDs (STIs) HIV/AIDS Chlamydia Gonorrhea Human
More informationHIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP
HIV: Pregnancy in Serodiscordant Couple Dr Chow TS ID Clinic HPP Sexual Reproductive Health and Rights The recognition of the sexual and reproductive health and rights (SRHR) of all individuals and couples
More informationGuidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Visit the AIDSinfo website to access the most up-to-date guideline. Register for e-mail notification of guideline
More informationSession 1B - Auditorium Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now
More informationART for HIV Prevention:
ART for HIV Prevention: KENNETH H. MAYER, M.D. Brown University/The Fenway Institute August 22, 2009 APPROACHES TO PREVENT HIV TRANSMISSION DECREASE SOURCE OF INFECTION Barrier Protection Treat STI Antiretroviral
More informationFAMILY HIV CENTER NJ CARES SANE
HIV, Hepatitis B & C Postexposure Prophylaxis for Sexual Assault Victims Update for Case Managers Susan Burrows-Clark, RN, MSN, CNS, C. 10/17/11 Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug
More informationPediatric HIV Update NORTHWEST AIDS EDUCATION AND TRAINING CENTER
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Pediatric HIV Update Christian B. Ramers, MD, MPH Assistant Medical Director, Family Health Centers of San Diego HIV/HCV Distance Education Specialist - NWAETC,
More informationObjectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)
Objectives Prevention of Mother-to-Child Transmission (PMTCT) Teen Club Community Partners Training Programme By the end of the session participants will be able to: 1. Identify factors affecting the transmission
More informationImportance of Viral Suppression to Reduce HIV Transmission: Recent Evidence
Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine Viral suppression
More informationEmtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Training Guide for Healthcare Providers
Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Training Guide for Healthcare Providers About emtricitabine/tenofovir disoproxil fumarate for HIV-1 PrEP
More informationPregnancy and HIV Reviewing the Vertical Transmission Risks 2015 OCN Education Day V Logan Kennedy RN, MN Research Associate and Clinical Nursing
Pregnancy and HIV Reviewing the Vertical Transmission Risks 2015 OCN Education Day V Logan Kennedy RN, MN Research Associate and Clinical Nursing Specialist Women s College Research Institute, Women s
More informationPrevention of Mother to Child Transmission of HIV: Our Experience in South India
pg 62-66 Original Article Prevention of Mother to Child Transmission of HIV: Our Experience in South India Karthekeyani Vijaya 1, Alexander Glory 2, Solomon Eileen 3, Rao Sarita 4, Rao P.S.S.Sunder 5 1
More informationContraception update. Gina M. Brown, M.D.
Contraception update Gina M. Brown, M.D. IUDs cannot be used in HIV + women Women with thromboembolic disease can never use hormonal contraception Combined hormonal contraception increases blood pressure
More informationContraception update. Gina M. Brown, M.D.
Contraception update Gina M. Brown, M.D. IUDs cannot be used in HIV + women Women with thromboembolic disease can never use hormonal contraception Combined hormonal contraception increases blood pressure
More informationWhat you need to know to: Keep Yourself SAFE!
What you need to know to: Keep Yourself SAFE! What are sexually transmitted diseases (STDs)? How are they spread? What are the different types of STDs? How do I protect myself? STDs are infections or diseases
More informationINTERPROFESSIONAL PROTOCOL - MUHC
INTERPROFESSIONAL PROTOCOL - MUHC Medication included No Medication included THIS IS NOT A MEDICAL ORDER Title: PREVENTION OF MATERNAL TO INFANT HIV INFECTION Intrapartum, Peripartum, and Postpartum Antiretroviral
More informationFigure S1: Overview of PMTCT Options A and B. Prevention of Mother to Child HIV Transmission (PMTCT)
Figure S1: Overview of PMTCT Options A and B Prevention of Mother to Child HIV Transmission (PMTCT) Option A: combined Antiretroviral therapy (ART) for all women meeting WHO 2010 criteria for initiation
More informationAddressing HIV Disparities Among Women Of Color In The Southern United States
Addressing HIV Disparities Among Women Of Color In The Southern United States www.healthhiv.org Women of Color Living With HIV A s an increasing number of women in the United Factors Influencing HIV Rates
More informationGENITAL HERPES. 81.1% of HSV-2 infections are asymptomatic or unrecognized. Figure 14 HSV-2 seroprevalence among persons aged years by sex.
GENITAL HERPES Genital herpes is a chronic, lifelong, sexually transmitted disease caused by herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). HSV-1 typically causes small, painful, fluid-filled,
More informationEuropean AIDS Clinical Society (EACS) Guidelines for the Clinical Management and Treatment of HIV Infected Adults in Europe
European AIDS Clinical Society (EACS) Guidelines for the Clinical Management and Treatment of HIV Infected Adults in Europe PANEL MEMBERS Nathan Clumeck, Treasurer Chair, Brussels, Belgium Anton Pozniak,
More informationSimplifying HIV Treatment Now and in the Future
Simplifying HIV Treatment Now and in the Future David M. Hachey, Pharm.D., AAHIVP Professor Idaho State University Department of Family Medicine Nothing Disclosure 1 Objectives List current first line
More informationHIV Update Objectives. Epidemiology. Epidemiology, Transmission and Natural History. Transmission Risk by Exposure. Transmission 9/29/2014
Objectives HIV Update 2014 Jay Sizemore, MD, MPH Medical Director Chattanooga CARES Assistant Professor UTCOM Chattanooga 2October 2014 Review HIV epidemiology and screening/testing guidelines Discuss
More informationEpatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici. Ivana Maida
Epatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici Ivana Maida Positivity for HBsAg was found in 0.5% of tested women In the 70s and 80s, Italy was one of the European countries
More informationUsing new ARVs in pregnancy
Using new ARVs in pregnancy Linda-Gail Bekker With thanks to CN Mnyani SA HIV Clinician s Society Meeting 3 June 2017 We have effective drugs. There is no reason why any mother should die of AIDS. There
More informationCare of the HIV-Exposed Infant
Care of the HIV-Exposed Infant Use of Flipchart To promote quality and consistency of counseling Why use the counseling flipchart? To improve HIV-exposed infant outcomes through high quality counseling.
More informationContraception and gynecological pathologies
1 Contraception and gynecological pathologies 18 years old, 2 CMI normal First menstruation at 14 years old Irregular (every 2/3 months), painful + She does not need contraception She is worried about
More informationnevirapine, zidovudine and lamivudine
nevirapine, zidovudine and lamivudine a fixed dose ART combination for HIV treatment http://www.aidsmap.com/hatip nevirapine. zidovudine and lamivudine (non-fixed dose) 2 Information on starting treatment
More informationPediatric HIV Infection and the Medical Management of Pregnant Women infected with HIV. Ernesto Parra, M.D., M.P.H.
Pediatric HIV Infection and the Medical Management of Pregnant Women infected with HIV Ernesto Parra, M.D., M.P.H. Adjunct Associate Professor UTHSCSA Department of Pediatrics and Family and Community
More informationDiagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know
Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know Carolyn K. Burr, EdD, RN Co-Clinical Director Deputy Director François-Xavier Bagnoud Center December 17 th, 2013
More informationPediatric HIV Cure Research
Pediatric HIV Cure Research HIV Cure Research Training Curriculum Pediatric HIV Cure Research Presented by: Priyanka Uprety,MSPH, PhD Laboratory of Deborah Persaud, MD Johns Hopkins University July 2016
More informationMother-to-Child transmission of hiv and neonatal hiv ManageMent
Mother-to-Child transmission of hiv and neonatal hiv ManageMent Perinatal transmission of the human immunodeficiency virus (HIV), or mother-to-child transmission (MTCT), occurs when a mother living with
More informationCost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1 Halpern M T, Read J S, Ganoczy D A, Harris D R
Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1 Halpern M T, Read J S, Ganoczy D A, Harris D R Record Status This is a critical abstract of an economic
More informationComparison of Drug Treatment Protocols for Children Infected with HIV in Washington, DC and Cape Town, South Africa in Relation to NIH Guidelines
Comparison of Drug Treatment Protocols for Children Infected with HIV in Washington, DC and Cape Town, South Africa in Relation to NIH Guidelines Mariah M. Marshall Department of Human Science Georgetown
More information1. Africa Centre for Health and Population Studies 2. London School of Hygiene and Tropical Medicine 3. University College London
A systematic review of the effects of interrupted antiretroviral interventions for prevention of mother-to-child transmission of HIV on maternal disease progression and survival Naidu KK 1, Mori R 2, Newell
More information